ConductScience.org, home

Paper2188586

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.

Fantin B and 9 others. Antimicrob Agents Chemother, 1990. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Papers, record 2188586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2188586

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2021-05-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fantin BB
2Pangon BB
3Potel GG
4Caron FF
5Vallée EE
6Vallois JMJ M
7Mohler JJ
8Buré AA
9Philippon AA
10Carbon CC

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CeftriaxoneMajor topic
Endocarditis, BacterialMajor topic
Escherichia coliMajor topic
Escherichia coli InfectionsMajor topic
SulbactamMajor topic
beta-Lactamase InhibitorsMajor topic
Animals
Drug Combinations
Female
Microbial Sensitivity Tests
Netilmicin
Rabbits

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1848924Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/848924PubMed
26416161Properties of PSE-2 beta-lactamase and genetic basis for its production in Pseudomonas aeruginosa.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6416161PubMed
37447427Method of reliable determination of minimal lethal antibiotic concentrations.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447427PubMed
46268715Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.J Infect Dis1981https://conductscience.org/library/papers/6268715PubMed
56307964Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.J Antimicrob Chemother1983https://conductscience.org/library/papers/6307964PubMed
63879659Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3879659PubMed
73026019Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.Rev Infect Dis1986https://conductscience.org/library/papers/3026019PubMed
83579254Ion pair high-performance liquid chromatographic assay for ceftriaxone.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3579254PubMed
93300530Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300530PubMed
102886766Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.Lancet1987https://conductscience.org/library/papers/2886766PubMed
113324957Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3324957PubMed
123360686Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins.J Antimicrob Chemother1988https://conductscience.org/library/papers/3360686PubMed
133055176Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins.Rev Infect Dis1988https://conductscience.org/library/papers/3055176PubMed
143263690Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.Rev Infect Dis1988https://conductscience.org/library/papers/3263690PubMed
152665645Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2665645PubMed
162679367Extended-spectrum beta-lactamases.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2679367PubMed
176350256Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins.J Antimicrob Chemother1983https://conductscience.org/library/papers/6350256PubMed
186353526Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.Rev Infect Dis1983https://conductscience.org/library/papers/6353526PubMed
1996731Beta-lactamases: determination of their isoelectric points.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/96731PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
31170287Inoculum effect of β-lactam antibiotics.J Antimicrob Chemother2019https://conductscience.org/library/papers/31170287PubMed
24321187A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.Ann Clin Microbiol Antimicrob2013https://conductscience.org/library/papers/24321187PubMed
16223952Extended-spectrum beta-lactamases: a clinical update.Clin Microbiol Rev2005https://conductscience.org/library/papers/16223952PubMed
11585791Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.Clin Microbiol Rev2001https://conductscience.org/library/papers/11585791PubMed
11376058Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.J Clin Microbiol2001https://conductscience.org/library/papers/11376058PubMed
10081693Extended-spectrum beta-lactamase-producing Salmonella enteritidis in Trinidad and Tobago.Emerg Infect Dis1999https://conductscience.org/library/papers/10081693PubMed
9230382Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center.J Clin Microbiol1997https://conductscience.org/library/papers/9230382PubMed
9145868Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9145868PubMed
9087477Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9087477PubMed
8789016Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.J Clin Microbiol1996https://conductscience.org/library/papers/8789016PubMed
8195380Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.J Clin Microbiol1994https://conductscience.org/library/papers/8195380PubMed
7625813In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7625813PubMed
2128443Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2128443PubMed
2073099Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2073099PubMed
1952834More extended-spectrum beta-lactamases.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1952834PubMed
1929273Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1929273PubMed
1834013Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1834013PubMed
1510412In vivo antibiotic synergism: contribution of animal models.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1510412PubMed
1444286Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1444286PubMed
1329634Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329634PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2188586

GET https://conductscience.org/api/papers/v1/2188586/authors